119 SRES 436 ATS: Expressing support for the designation of September 2025 as “National Prostate Cancer Awareness Month”. U.S. Senate 2025-10-06 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

III119th CONGRESS1st SessionS. RES. 436IN THE SENATE OF THE UNITED STATESOctober 6, 2025Mr. Crapo (for himself, Mr. Booker, Mr. Risch, and Mr. Van Hollen) submitted the following resolution; which was considered and agreed toRESOLUTIONExpressing support for the designation of September 2025 as National Prostate Cancer Awareness Month.

Whereas more than 3,300,000 men are living with prostate cancer in the United States;Whereas 1 in 8 men in the United States will be diagnosed with prostate cancer in their lifetimes and 1 in 41 men in the United States will die from prostate cancer;Whereas prostate cancer is the most commonly diagnosed non-skin cancer and the second-leading cause of cancer-related deaths among men in the United States;Whereas the American Cancer Society estimates that, in 2025, 313,780 men will be diagnosed with, and more than 35,770 men will die of, prostate cancer;Whereas 35 percent of newly diagnosed prostate cancer cases occur in men under the age of 65;Whereas the odds of developing prostate cancer rise rapidly after age 50;Whereas having a father or brother with prostate cancer more than doubles the risk of a man developing prostate cancer, with a higher risk for men who have a brother with the disease and the highest risk for men with several affected relatives;Whereas screening by a digital rectal examination and a prostate-specific antigen blood test may be able to detect the disease at an early stage;Whereas, when diagnosed with localized- or regional-stage prostate cancer, the survival rate nears 100 percent;Whereas only 37 percent of men survive more than 5 years if diagnosed with prostate cancer after the cancer has metastasized;Whereas there are typically no noticeable symptoms of prostate cancer in the early stages, making discussions with a doctor regarding appropriate screening critical;Whereas, in fiscal year 2025, Congress appropriated $48,551,000,000 to the National Institutes of Health, including $7,220,000,000 for the National Cancer Institute;Whereas, in fiscal year 2025, Congress appropriated $75,000,000 for the Prostate Cancer Research Program of the Department of Defense;Whereas the Department of Veterans Affairs has established 21 Precision Oncology Centers of Excellence in order to deliver precision oncology services to veterans suffering from prostate cancer;Whereas ongoing research promises further improvements in prostate cancer prevention, early detection, and treatment; andWhereas educating individuals in the United States, including health care providers, about prostate cancer and early detection strategies while emphasizing the importance of consultation with a physician regarding the benefits and risks of screening is essential to saving lives and preserving and protecting families: Now, therefore, be it

That the Senate—(1)expresses support for the designation of National Prostate Cancer Awareness Month;(2)declares that steps should be taken—(A)to raise awareness about the importance of screening methods for, and treatment of, prostate cancer;(B)to encourage research—(i)to improve screening and treatment for prostate cancer;(ii)to discover the causes of prostate cancer; and(iii)to develop a cure for prostate cancer; and(C)to continue to consider ways to improve access to, and the quality of, health care services for detecting and treating prostate cancer; and(3)calls on the people of the United States, interest groups, and affected persons—(A)to promote awareness of prostate cancer;(B)to take an active role in the fight to end the devastating effects of prostate cancer on individuals, families, and the economy; and(C)to observe National Prostate Cancer Awareness Month with appropriate ceremonies and activities.